Page last updated: 2024-09-05

sorafenib and serine

sorafenib has been researched along with serine in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(serine)
Trials
(serine)
Recent Studies (post-2010) (serine)
6,5207305,25123,9141156,084

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)serine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.015
CholinesteraseEquus caballus (horse)0.016

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Biondi, RM; Brieger, A; Hinrichsen, I; Huhn, M; Passmann, S; Plotz, G; Weßbecher, IM; Zeuzem, S1
Chen, C; Deng, Q; Li, J; Shao, C; Shi, Z; Sun, H; Tang, W; Xiao, J; Xuan, Z; Ye, S; Yue, J; Zhang, L; Zhao, Y; Zheng, J; Zhu, F1

Other Studies

2 other study(ies) available for sorafenib and serine

ArticleYear
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:12

    Topics: Blotting, Western; Enzyme Inhibitors; HEK293 Cells; Humans; Marine Toxins; Mismatch Repair Endonuclease PMS2; Mutation; MutL Protein Homolog 1; MutL Proteins; Niacinamide; Oxazoles; Phenylurea Compounds; Phosphorylation; Proteolysis; Serine; Signal Transduction; Sorafenib; Threonine

2017
TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
    Cell death & disease, 2022, 05-11, Volume: 13, Issue:5

    Topics: Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Humans; Kidney Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Serine; Sorafenib

2022